[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617558":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":18,"responsibleParty":34,"collaborators":36,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":18,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":62,"whyStopped":18,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":18},{"fullName":5,"class":6},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients taking Pervistop","EXPERIMENTAL","24 couples in which both partners will receive a supplement containing EGCG (200 mg), vitamin B12 (1 mg), hyaluronic acid (50 mg), and folic acid (400 μg), one tablet daily orally for 6 month",[13],"Dietary Supplement: pervistop",{"label":15,"type":16,"description":17,"interventionNames":18},"Patients no taking Pervistop","NO_INTERVENTION","24 couples with no supplementation.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DIETARY_SUPPLEMENT","pervistop","combination of EGCG, vitamin B12, hyaluronic acid, and folic acid",[9],[26],{"name":27,"affiliation":5,"role":28},"Domenico Milardi","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","3394826008","domenico.milardi@policlinicogemelli.it",{"type":35,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[37],{"name":38,"class":39},"Lo.Li.Pharma s.r.l","INDUSTRY","100617558","effect-of-a-dietary-supplement-containing-egcg-folic-acid-vitamin-b12-and-hyaluronic-acid-in-supporting-male-genital-balance-in-subjects-exposed-to-hpv-risk-100617558",false,"NCT07320183","Effect of a Dietary Supplement Containing EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid in Supporting Male Genital Balance in Subjects Exposed to HPV Risk","PERVI-M","Inclusion Criteria:\n\n* Signed informed consent\n* Couple seeking pregnancy\n* Male partner aged 25-65 years\n* HPV DNA test indicating active HPV infection in the male partner\n* HPV DNA test indicating negativity for HPV infection in the female partner\n\nExclusion Criteria:\n\n* Concomitant diseases causing immunosuppression\n* Treatment with immunomodulatory therapies\n* Use of EGCG or other green tea extracts","ALL","25 Years","65 Years",{"count":51,"type":52},96,"ESTIMATED","INTERVENTIONAL",[55],"NA","Pilot interventional study aimed at evaluating the effect of a dietary supplement containing EGCG, vitamin B12, hyaluronic acid, and folic acid on the maintenance of physiological balance of the genital mucosa and natural defenses of the male genital tract, as well as on the maintenance of HPV-DNA test negativity, in subjects undergoing natural procreation pathways. The study will also assess the potential support of sperm parameters, reproductive well-being of the couple, and the reduction of risk factors associated with HPV transmission to the female partner. A total of 34 HPV-positive couples attending the Istituto Scientifico Internazionale \"Paolo VI\" of the Policlinico A. Gemelli will be enrolled and randomized into two groups: 17 couples in the intervention group, in which the male partner will receive the supplement (EGCG 200 mg, vitamin B12 1 mg, hyaluronic acid 50 mg, folic acid 400 μg, one tablet daily for 6 months), and 17 couples in the control group with no supplementation.",[58,59],"HPV - Anogenital Human Papilloma Virus Infection","Infertilities",[61],"HPV- infertility","NOT_YET_RECRUITING","2026-01-07",{"date":65,"type":66},"2026-01-08","ACTUAL",{"date":68,"type":52},"2026-03-01",{"date":70,"type":52},"2028-03",{"name":5,"class":6}]